TRACY IRENE GEORGE portrait
  • Professor (Clinical), Pathology
801-583-2787

Presentations

  • George, TI. Histopathology changes during KIT inhibitor therapy. 2022 AIM Physician & Investigator Conference, American Initiative in Mast Cell Diseases, Salt Lake City, UT. , Presented, 2022.
  • George TI. Histopathology of eosinophil disorders. Year 2021 Working Conference on Eosinophil Disorders and Related Syndromes, Vienna, Austria (virtual). , Presented, 2021.
  • George TI, Report and Summary of WP1: Pathology. Year 2020 Working Conference on Mast Cell Disorders, Vienna, Austria (virtual). , Presented, 2020.
  • George TI, CD30 as Novel SM Criterion: Histopathological Evidence. Year 2020 Working Conference on Mast Cell Disorders, Vienna, Austria (virtual). , Presented, 2020.
  • George TI. Current Concepts in Mastocytosis. Houston Methodist Cancer Symposium, webinar. , Presented, 2020.
  • George, TI, How to Get Your Work Published, International Society of Laboratory Hematology Annual Meeting, Vancouver, Canada. , , 2019.
  • George, TI, Bone Marrow Pathology in the Diagnosis of Mast Cell Disease. American Initiative in Mast Cell Diseases Inaugural Investigator Conference, Stanford University, Stanford, CA. , , 2019.
  • George, TI, Bone Marrow and Gastrointestinal Pathology in Mast Cell Disease, The Mastocytosis Society 25th Annual Conference, Foster City, CA. , , 2019.
  • George TI, Updates on Mast Cell Disease, Department of Pathology, Stanford University, Stanford, CA. , Presented, 2019.
  • George TI, Diagnostic Challenges: The Pathologists Perspective. 2019 Bone Marrow Failure and Myeloid Neoplasia Symposium: Advances in Diagnosis and Treatment. AA and MDS International Foundation. Albuquerque, NM. , , 2019.
  • George TI. Diagnosis and management of clonal hematopoiesis (including ICUS and CHIPs). Turkish Society of Hematology, 44th National Congress of Hematology, Antalya, Turkey. , , 2018.
  • George TI, Advances in Acute Myeloid Leukemia, Daiichi Sankyo, Inc, Visiting Professorship, Basking Ridge, NJ. , , 2018.
  • George TI Developments in Advanced Systemic Mastocytosis: Understanding Diagnosis and Treatment Options. Advanced Systemic Mastocytosis Virtual Expert Forum. Novartis. Frankfurt, Germany. , , 2018.
  • George TI. Diagnosis and management of clonal hematopoiesis. Korean Society of Laboratory Medicine Spring Symposium, Seoul, Korea. , , 2018.
  • George TI. Bone Marrow Manifestations of Systemic Disease. Educational course with Dita Gratzinger and David Czuchlewski, United States and Canadian Academy of Pathology Annual Meeting, Vancouver, Canada. , , 2018.
  • George TI, Bone marrow pathology in mastocytosis. BLU 285-2101 Blueprint Medicines Study Investigator Meeting, Berlin, Germany. , , 2018.
  • George TI, Identification of new potential therapeutic targets in advanced SM. Session 6: Preclinical Development of New Treatments in Mastocytosis, The European Competence network on Mastocytosis, (ECNM) 16th Annual Meeting, Salerno, Italy. , , 2018.
  • George TI. Bone Marrow Manifestations of Systemic Disease. Educational course with Dita Gratzinger and David Czuchlewski, United States and Canadian Academy of Pathology Annual Meeting, San Antonio, TX. , , 2017.
  • George TI. Practice Controversies in Ancillary Testing Choices. Educational course with Sherrie Perkins, International Society of Laboratory Hematology Annual Meeting, Honolulu, HI. , , 2017.
  • George TI. Lymphoid Aggregates: Benign versus Malignant. Thedacare Laboratories, Appleton, WI. , , 2017.
  • George TI. Myeloproliferative Neoplasms: From Diagnosis to Clinical Decision Making in the Age of Molecular Medicine. Educational course with Annette Kim and Olga Pozdnyakova, American Society for Clinical Pathology 2017 Annual Meeting, Chicago, IL. , , 2017.
  • George TI. A Practical State-of-the-Art Approach to Diagnostic Hematopathology. American Society for Clinical Pathology Hematopathology Educational Course, Chicago, IL. , , 2017.
  • George TI. A Modern Approach to Myeloid Neoplasms. Educational course with Robert Ohgami and Brent Tan, California Society of Pathology Annual Meeting, San Francisco, CA. , , 2017.
  • George TI. Peripheral Blood Refresher: a Case-Based Approach. Educational course with Devon-Chabot Richards, College of American Pathologists Annual Meeting, Las Vegas, NV. , , 2016.
  • George TI. Bone Marrow Manifestations of Systemic Disease. Educational course with Dita Gratzinger, David Czuchlewski, United States and Canadian Academy of Pathology Annual Meeting, Seattle, WA. , , 2016.
  • George TI. MDS III Tumor Board. Educational course with Rafael Bejar, Robert Hasserjian, and Joyce Rogers on behalf of American Society for Clinical Pathology, American Society of Hematology, and The France Foundation. American Society for Clinical Pathology Annual Meeting, Las Vegas, NV. , , 2016.
  • George TI. What genomics imply about the what and where of the WHO for MDS. Educational course on behalf of American Society for Clinical Pathology, American Society of Hematology, and The France Foundation, American Society of Hematology Annual Meeting, San Diego, CA. , , 2016.
  • George TI. Practical diagnosis of myeloproliferative neoplasms in the current era: why pathology matters. Educational course with Robert Hasserjian and Olga Pozdnyakova, American Society for Clinical Pathology Annual Meeting, Las Vegas, NV. , , 2016.
  • George TI. The Diagnosis, Classification and Clinical Care of MDS III.” Educational course on behalf of American Society for Clinical Pathology, American Society of Hematology, and The France Foundation, American Society for Clinical Pathology Oncology Updates, Austin, TX. , , 2016.
  • George TI. Proliferative aspects of mast cells and mastocytosis. Session VIII: Pathology and Molecular Markers in SM, The European Competence Network on Mastocytosis (ECNM) Annual Meeting, Verona, Italy. , , 2016.
  • George TI. The Diagnosis, Classification and Clinical Care of MDS. Educational course on behalf of American Society for Clinical Pathology, American Society of Hematology, and The France Foundation, San Francisco, CA. , , 2015.
  • George TI. Leukocytosis, erythrocytosis, thrombocytosis. Webinar for International Society of Laboratory Hematology. , , 2015.
  • George TI. Practical diagnosis of myeloproliferative neoplasms in the current era: why pathology matters. Educational course with Robert Hasserjian and Olga Pozdnyakova, American Society for Clinical Pathology Annual Meeting, Long Beach, CA. , , 2015.
  • George TI. Morphologic mimics of MDS. Educational course on behalf of American Society for Clinical Pathology, American Society of Hematology, and The France Foundation. American Society for Clinical Pathology Annual Meeting, Long Beach, CA. , , 2015.
  • George TI. Practical Approach to Peripheral Blood Smear Evaluation. Educational course with Joan Etzell and Anne Deucher, College of American Pathologists Annual Meeting, Nashville, TN. , , 2015.
  • George TI. The Diagnosis, Classification and Clinical Care of MDS. Educational course on behalf of American Society for Clinical Pathology, American Society of Hematology, and The France Foundation, Chicago, IL. , , 2015.
  • George TI. Novel immunophenotypic markers in mastocytosis. Mast Cells and Mastocytosis - In Memoriam Paul Ehrlich (1854-1915), Medical University of Vienna, Vienna, Austria. , , 2015.
  • George TI. An Algorithmic Approach to Laboratory Hematology. Educational course with Joan Etzell and Sherrie Perkins, American Association of Clinical Chemistry Annual Meeting, Atlanta, GA. , , 2015.
  • George TI. Leukocytosis, erythrocytosis, thrombocytosis. Educational Workshop: Updates and Guidelines in Laboratory Hematology: What’s Current and Practical?, International Society of Laboratory Hematology Annual Meeting, Chicago, IL. , , 2015.
  • George TI. Update on diffuse large B cell lymphoma. The Cancer Center at Presbyterian, Kaseman Hospital, Albuquerque, NM. , , 2014.
  • George TI. Myeloproliferative Neoplasms (MPN) and MPN Variants - Practical Approach to Diagnosis and Monitoring. Educational course with LoAnn Peterson, American Society for Clinical Pathology Annual Meeting, Tampa, FL. , , 2014.
  • George TI. From WHO to New: Updated Approaches to Neoplastic Hematopathology for 2014. Educational course with David Czuchlewski, American Society for Clinical Pathology Annual Meeting, Tampa, FL. , , 2014.
  • George TI. An Algorithmic Approach to Laboratory Hematology. Educational course with Joan Etzell and Sherrie Perkins, American Association of Clinical Chemistry Annual Meeting, Chicago, IL. , , 2014.
  • George TI. Practical Approach to Peripheral Blood Smear Evaluation. Educational course with Joan Etzell and Anne Deucher, College of American Pathologists Annual Meeting, Chicago, IL. , , 2014.
  • George TI. Evaluation of Leukocytosis. Educational webinar, Sysmex. , , 2014.
  • George TI. Myeloproliferative Neoplasms (MPN) and MPN Variants - Practical Approach to Diagnosis and Monitoring. Educational course with LoAnn Peterson, American Society for Clinical Pathology Annual Meeting, Chicago, IL. , , 2013.
  • George TI. Mast cell leukemia. CPKC412D2201 Steering Committee, Novartis. Venice, Italy. , , 2013.
  • George TI. Practical Approach to Peripheral Blood Smear Evaluation. Educational course with Joan Etzell and Anne Deucher, College of American Pathologists Annual Meeting, Orlando, FL. , , 2013.
  • George TI. Prevalence of Systemic Mastocytosis in Select Myeloid Malignancies- a Single Institution’s Experience. Consensus Panel Meeting on Diagnostic Criteria and Classification of Mastocytosis, Brigham and Women’s Hospital Mastocytosis Center, Harvard Medical School, Boston, MA. , , 2012.
  • George TI. Midostaurin in Advanced Mastocytosis. Symposium on Mastocytosis, Brigham and Women’s Hospital Mastocytosis Center, Harvard Medical School, Boston, MA. , , 2012.
  • George TI. Myeloid Neoplasms: Morphology to Molecular Genetics. Educational course with Daniel Arber, College of American Pathologists Annual Meeting, San Diego, CA. , , 2012.
  • George TI. Of mast cells and mastocytosis. ARUP Laboratories, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT. , , 2012.
  • George TI. Mast cell disease. Department of Pathology, Boston Children’s Hospital, Boston, MA. , , 2012.
  • George TI. Eosinophilia and Mast Cells in Myeloproliferative Neoplasms: ASM-eo versus ASM-CEL versus MPN-eo. Consensus Panel Meeting on Diagnostic Criteria and Classification of Mastocytosis, Brigham and Women’s Hospital Mastocytosis Center, Harvard Medical School, Boston, MA. , , 2012.
  • George TI. Acute myeloid leukemia and occult mastocytosis. European Bone Marrow Working Group X International Course on Bone Marrow Pathology, The Old Royal Naval College, University of Greenwich, London, England, UK. , , 2011.
  • Arredondo A, Jennings C, Shier L, Sundram U, Gotlib J, George TI. CD30 expression in systemic and cutaneous mastocytosis. European Competence Network in Mastocytosis Annual Meeting, Istanbul, Turkey. , , 2011.
  • George TI. JAK Who? Update on the 2008 WHO Classification and Clinical Management of Myeloproliferative Neoplasms. Educational course with Jason Gotlib, College of American Pathologists Annual Meeting, Chicago, IL. , , 2010.
  • George TI. Myelomastocytic leukemia versus mast cell leukemia versus SM-MDS. Session III: Molecular Pathology in MDS, Standards and Standardization in Hematopathology in MDS: EU-US initiative to standardize parameters of disease and diagnostics for practice and clinical trials in patients with MDS, Medical University of Vienna, Vienna, Austria. , , 2010.
  • George TI. Myelofibrosis, histologic features. Arresto BioSciences, Redwood City, CA. , , 2010.
  • George TI. Updates on the Diagnosis and Classification of Myeloproliferative Neoplasms. University Medical Center, Utrecht, Netherlands. , , 2009.
  • George TI. Myelomastocytic leukemia versus mast cell leukemia versus SM-AML: a diagnostic challenge. The European Competence Network on Mastocytosis (ECNM), Gdansk, Poland. , , 2009.
  • George TI. Clinical Microscopy of CSF and Body Fluids: Overview & Focus on Quality Assurance. Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM. , , 2008.
  • George TI. Principles & Practice of Flow Cytometry, Implications for Clinical Diagnosis. California Association for Medical Laboratory Technology, San Luis Obispo Chapter, Annual Meeting, Sierra Vista Medical Center, San Luis Obispo, CA. , , 2003.
  • George TI. Biology of Cancer. California Polytechnic Institute, San Luis Obispo, CA. , , 2002.
  • George TI. Updates in Flow Cytometry. Twin Cities Regional Medical Center, Templeton, CA. , , 2002.
  • George TI, Histologic Response Assessment in Advanced SM: Status 2021. The 19th Annual Meeting of the European Competence Network on Mastocytosis (ECNM), Brno, Czechia (virtual). , Presented, 2021.
  • George TI, Session 9: Systemic mastocytosis with associated hematological neoplasms (SM-AHN). Society of Hematopathology 2019 Fall Workshop on Eosinophilia and Mastocytosis, Phoenix, AZ. , Presented, 2019.
  • George, TI. Microscopy of CSF and Body Fluids. Fairview Diagnostic Laboratories, Fairview Health Services, Minneapolis/ St. Paul, Minnesota. , , 2019.
  • George TI, Case Presentation to ICL Laboratory, ARUP Laboratories, Salt Lake City, UT. , , 2019.
  • George TI, Morphologic Mimics of Lymphoma: What Every Practicing Pathologist Needs to Know. ARUP Laboratories, 32nd Annual Park City Anatomic Patology Update, Park City, Utah. , , 2019.
  • George TI. Bone Marrow & Skin Lesion Pathology. BLU-285-2203 Investigator Meeting. Melia Stiges, Barcelona, Spain. , , 2018.
  • George TI. Morphologic Mimics of Myelodysplasia. Session: Myelodysplastic Syndrome (MDS) Morphology, 18th Annual Meeting of Japanese Society for Laboratory Hematology/ International Society for Laboratory Hematology Joint Symposium, Sapporo, Japan. , , 2017.
  • George TI. Clinicopathologic features of mast cell leukemia. The European Competence Network on Mastocytosis (ECNM) Annual Meeting, Paris, France. , , 2017.
  • George TI. From Bench to Bedside: Advances in Mastocytosis. International Society of Laboratory Hematology Annual Meeting, Milano, Italy. , , 2016.
  • George TI. The Diagnosis, Classification and Clinical Care of MDS. 6th Emirates Hematology Conference with American Society for Clinical Pathology and the Emirates Hematology Society, Dubai, United Arab Emirates. , , 2016.
  • George TI. Panel discussion on implementation of the ACGME Milestones for Hematopathology. Program Director’s meeting, United States and Canadian Academy of Pathology Annual Meeting, Seattle, WA. , , 2016.
  • George TI. Overview of Mastocytosis. Mastocytosis Registry Curation and Patient Crossroads webinar, Albuquerque, NM. , , 2016.
  • George TI. Leukocytosis--when to get worked up? World Forum, International Society of Laboratory Hematology Annual Meeting, Hague, Netherlands. , , 2014.
  • George TI. New immunophenotypic assays in mastocytosis. The European Competence Network on Mastocytosis (ECNM) Annual Meeting, Odense, Denmark. , , 2014.
  • George TI. Bone Marrow and Tissue pathology in Patients with Mast Cell Disease. The Mastocytosis Society 20th Annual Conference, Rochester, MN. , , 2014.
  • George TI. Pathology: What Confirms a Mast Cell Disorder in Tissue Samples. The Mastocytosis Society 20th Annual Conference, Rochester, MN. , , 2014.
  • George TI. Challenging Hematopathology Cases. International Society of Laboratory Hematology Annual Meeting, Toronto, Canada. , , 2013.
  • George TI. Malignant or Benign Leukocytosis. Education Program session, Pearls and Pitfalls in the Hematology Lab: Updates on Cellular Diagnostics, 54th American Society of Hematology Annual Meeting, Atlanta, GA. , , 2012.
  • George TI. Diagnosis and monitoring of myeloproliferative neoplasms. Best of International Society of Laboratory Hematology, HEMO 2012, Brazilian Hematology, Hemotherapy and Cell Therapy Meeting, Rio de Janeiro, RJ, Brazil. , , 2012.
  • George TI. Myeloproliferative neoplasms-a case-based presentation. Session 9: Laboratory testing for hematological malignancies, International Society of Laboratory Hematology Annual Meeting, Nice, France. , , 2012.
  • George TI. Overview on the diagnosis and classification of myeloproliferative neoplasms. Updates on diagnostic testing for myeloproliferative neoplasms, International Society of Laboratory Hematology Annual Meeting, New Orleans, LA. , , 2011.
  • George TI. Myeloid proliferations with eosinophilia and FGFR1 abnormalities. The European Competence Network on Mastocytosis (ECNM) Nobel Forum, Stockholm, Sweden. , , 2010.
  • George TI. Bone marrow histology assessment in mastocytosis patients treated with PKC412 (Midostaurin). The European Competence Network on Mastocytosis (ECNM), Budapest, Hungary. , , 2008.
  • George TI. Breast cancer: What is it? Who gets it? How do we treat it? Canyon Ranch Educational Seminars, Tucson, AZ. , , 2006.
  • George TI. Personalized medicine: myth or reality? Canyon Ranch Educational Seminars, Tucson, AZ. , , 2006.
  • George TI. Lack of expression of PDGFRb in Langerhans cell histiocytosis. United States & Canadian Academy of Pathology platform presentation, Hematopathology section, Atlanta, GA. , , 2006.
  • George TI. Case studies in Myeloproliferative Diseases. California Association for Medical Laboratory Technology Annual Meeting & Workshops, Santa Clara Convention Center, Santa Clara, CA. , , 2005.
  • George TI. Principles & Practice of Flow Cytometry, Implications for Clinical Diagnosis. California Association for Medical Laboratory Technology, San Luis Obispo Chapter, Annual Meeting, Sierra Vista Medical Center, San Luis Obispo, CA. , , 2003.
  • George TI. Updates in Flow Cytometry. Marian Medical Center, Santa Maria, CA. , , 2002.
  • George TI, Molecular Hematopathology Tumor Board, American Society of Hematology Annual Meeting, Orlando, FL. Panel, Presented, 2019.
  • Clinicopathologic Characteristics of Myeloid/ Lymphoid Neoplasms with PDGFRB Rearrangement: A Bone Marrow Pathology (BMPG) Study. Abstract ID #342. Presented at United States and Canadian Academy of Pathology 109th Annual Meeting. February 29 - March 5, 2020. Los Angeles, CA. Poster, Presented, 2020.
  • Pathologic Spectrum of Chronic Myeloid Neoplasms Harboring Concomitant Mutations in Myeloproliferative Neoplasm Driver Genes (JAK2/ MPL/ CALR) and SF3B1. Presented at United States and Canadian Academy of Pathology, 109th Annual Meeting, February 29 - March 5, 2020. Los Angeles, CA. Poster, Presented, 2020.
  • George TI, Cogle CR, Garcia-Manero G, Grinblatt DL, Komrokji R, Savona MR, Scott BL, Sekeres MA, Steensma DP, Flick ED, Kiselev P, Louis CU, Nifenecker M, Swern AS, Fourcar K (2019). Diagnostic Testing Patterns and Concordance with World Health Organization Criteria for Patients with Newly Diagnosed Myelodysplastic Syndromes in the Connect® MDS/AML Registry. Poster #4747. Presented at the 61st Annual Meeting of the American Society of Hematology (ASH); December 7 - 10, 2019; Orlando, FL. Poster, Accepted, 2019.
  • Akin C, Sabato V, Gotlib JR, Castells MC, Deininger M, Elberink O, Heaney ML, van Daele P, Deepit R, Triggiani M, DeAngelo D, Twose IA, Broesby-Olsen S, George TI, Hartmann K, Siebenhaar F, Reiter A, Panse J, Lin HM, Morrison A, Maurer M (2019). Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy. Poster # 2950. Presented at The 61st American Society of Hematology (ASH) Annual Meeting and Exposition, Orlando, FL. Poster, Presented, 2019.
  • Patel JL, Cogle CR, Foucar K, Grinblatt DL, Komrokji R, Savona MR, Scott BL, Sekeres MA, Steensma DP, Flick ED, Kiselev P, Louis CU, Nifenecker M, Swern AS, George TI. Diagnostic Testing Patterns for Ring Sideroblasts in Patients with Newly Diagnosed Lower-Risk Myelodysplastic Syndromes in the Connect MDS/ AML Disease Registry. Abstract # MDS-267. Presented at the Society of Hematologic Oncology 7th Annual Meeting, Houston, TX Sept 11-14, 2019. Poster, Presented, 2019.
  • Radia D, Deininger M, Gotlib J, Bose P, Drummond M, Hexner E, Robinson W, Quiery A, Winton E, George T, Horny H, Oren R, Shi H, Schmidt-Kittler O, Mar B, DeAngelo D. (2019) Avapritinib, a potent and selective inhibitor of KIT D816V, induces complete and durable responses in patients (PTS) with advanced systemic mastocytosis (ADVSM). Abstract #S830. Poster session presented at 24th Congress of EHA, Amsterdam, Netherlands. Poster, Presented, 2019.
  • Dimos B, Hatch E, George T, Lidke D. Quantum Dot Immunohistochemistry for Protein Detection in Systemic Mastocytosis. Poster session presented at University of New Mexico Undergraduate Pipeline Network Summer Research Session, Albuquerque, NM. Poster, Presented, 2014.

Languages

  • English, Fluent.

Publications

  • Gerds AT, Gotlib J, Bose P, Deininger MW, Dunbar A, Elshoury A, George, TI, Gojo I, Gundabolu K, Hexner E, Hobbs G, Jain T, Jamieson C, Kuykendall AT, McMahon B, Mohan SR, Oehler V, Oh S, Pardanani A, Podoltsev N, Ranheim E, Rein L, Salit R, Snyder DS, Stein BL, Talpaz M, Thota S, Vachhani P, Wadleigh M, Walsh K, Ward DC, Bergman MA, Sundar H (date unknown). Myeloid/ Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. doi: 10.6004/jnccn.2020.0042. PMID: 32886902. Vol. 18, 1248 - 1269. Accepted, .